Citation tools
"Immuno-PET using anti-CEA bispecific antibody and 68Ga-labeled peptide in metastatic medullary thyroid carcinoma: clinical optimization of the pretargeting parameters in a First-in Human trial." Journal of Nuclear Medicine
(2016):
jnumed.116.172221.
Web. 27 April. 2025.